This paper is published in Volume-4, Issue-4, 2018
Area
Pharmacy Practice
Author
Mathew George, Lincy Joseph, Dr. Sujith K, Monisha Mohan
Org/Univ
Pushpagiri College of Pharmacy, Thiruvalla, Kerala, India
Pub. Date
14 August, 2018
Paper ID
V4I4-1449
Publisher
Keywords
Cephalosporins, Drug utilisation pattern, Respiratory tract infection, Ceftriaxone

Citationsacebook

IEEE
Mathew George, Lincy Joseph, Dr. Sujith K, Monisha Mohan. A prospective study on drug utilisation pattern of cephalosporins in respiratory tract infections, International Journal of Advance Research, Ideas and Innovations in Technology, www.IJARIIT.com.

APA
Mathew George, Lincy Joseph, Dr. Sujith K, Monisha Mohan (2018). A prospective study on drug utilisation pattern of cephalosporins in respiratory tract infections. International Journal of Advance Research, Ideas and Innovations in Technology, 4(4) www.IJARIIT.com.

MLA
Mathew George, Lincy Joseph, Dr. Sujith K, Monisha Mohan. "A prospective study on drug utilisation pattern of cephalosporins in respiratory tract infections." International Journal of Advance Research, Ideas and Innovations in Technology 4.4 (2018). www.IJARIIT.com.

Abstract

Drug Utilization Pattern is defined by WHO in 1977 as "the marketing, distribution, prescription and the use of drugs in a society, with special emphasis on the resulting medical, social and economic consequences”. The aim is to evaluate the Drug Utilization Pattern of cephalosporins in respiratory tract infections. Methods: In a prospective observational study performed over a 6 months period (2017-2018), hospitalized adult patients who received cephalosporins for respiratory tract infections were selected. The collected data included demographic details, information regarding a cough, phlegm, periods of a cough and phlegm, breathlessness, wheezing, chest illness, past illness, tobacco, and smoking. Over the study period, 185 patients were evaluated. Lower Respiratory Tract infected patients (130) 70.3% were more than Upper Respiratory Tract (55) 29.7%. Majority patients came with a complaint of breathing (113) 61.1% difficulty following by acute exacerbation of COPD (39) 21.1%. First, second and third generation cephalosporins were prescribed. Out of which, the third generation were mostly prescribed than the other two; ceftriaxone 51.4% and cefixime 22.2 %.Around (83) 44.9% patients were having co-morbid conditions, diabetes followed by hypertension.